HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
2.656
+0.016 (0.61%)
At close: Mar 9, 2026, 4:00 PM EDT
2.870
+0.214 (8.06%)
After-hours: Mar 9, 2026, 7:40 PM EDT
HeartSciences Revenue
HeartSciences had revenue of $2.42K in the quarter ending October 31, 2025. This brings the company's revenue in the last twelve months to $8.67K, down -41.03% year-over-year. In the fiscal year ending April 30, 2025, HeartSciences had annual revenue of $4.35K, down -76.61%.
Revenue (ttm)
$8.67K
Revenue Growth
-41.03%
P/S Ratio
974.29
Revenue / Employee
$578
Employees
15
Market Cap
8.45M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Trinity Biotech | 48.57M |
| Lifeward | 24.50M |
| INVO Fertility | 6.94M |
| Beyond Air | 6.92M |
| Biomerica | 4.46M |
| Intelligent Bio Solutions | 3.58M |
| Tenon Medical | 3.23M |
| Sintx Technologies | 1.27M |
HSCS News
- 4 weeks ago - University of West England Adopts HeartSciences' MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center - GlobeNewsWire
- 5 weeks ago - Cibolo Health Designates HeartSciences' MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals - GlobeNewsWire
- 3 months ago - HeartSciences Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 3 months ago - HeartSciences Announces FDA 510(k) Submission for MyoVista® wavECG™ Device - GlobeNewsWire
- 3 months ago - HeartSciences Announces Major Upgrade to User Features of MyoVista Insights Platform with Commercial Launch Version 1.1 - GlobeNewsWire
- 6 months ago - HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results - GlobeNewsWire
- 7 months ago - HeartSciences Announces Conference Participation and Investor Webinar - GlobeNewsWire
- 8 months ago - HeartSciences Provides Business Update and Reports Fiscal 2025 Financial Results - GlobeNewsWire